CK Hutchison : GRANT OF SHARE OPTIONS BY HUTCHISON CHINA MEDITECH LIMITED

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GRANT OF SHARE OPTIONS

BY HUTCHISON CHINA MEDITECH LIMITED

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

The board of directors (the "Board") of CK Hutchison Holdings Limited (the "Company") announces that on 6 June 2018, 36,936 share options were granted by Hutchison China MediTech Limited ("HCML", an approximately 60.27% held subsidiary of the Company, whose shares are traded on the AIM market of the London Stock Exchange and in the form of American Depositary Shares on the NASDAQ Global Select Market) under its share option scheme (the "HCML Scheme", which was unconditionally adopted on 13 May 2016) to certain Eligible Employees (as defined in the HCML Scheme) (the "Grantees") to subscribe for ordinary shares of nominal value of US$1 each of HCML (each a "HCML Share"). Details of such share options are as follows:

Date of grant	: 6 June 2018
Exercise price of share options granted	: GBP41.66 per HCML Share
Number of share options granted	: 36,936 (each share option shall entitle
the holder thereof to subscribe for one
HCML Share)

Closing market price of the HCML Shares : GBP41.40 per HCML Share on the date of grant

Validity period of the share options : from 6 June 2018 to 5 June 2028

None of the Grantees is a director, chief executive nor substantial shareholder of HCML, or an associate (as defined under the Listing Rules) of any of them.

By Order of the Board

Edith Shih

Executive Director & Company Secretary

Hong Kong, 7 June 2018

As at the date of this announcement, the Directors of the Company are:

Executive Directors:

• Mr LI Tzar Kuoi, Victor (Chairman and Group Co-Managing Director)

• Mr FOK Kin Ning, Canning (Group Co-Managing Director)

• Mr Frank John SIXT (Group Finance Director and Deputy Managing Director)

• Mr IP Tak Chuen, Edmond

  (Deputy Managing Director)

• Mr KAM Hing Lam

  (Deputy Managing Director)

• Mr LAI Kai Ming, Dominic (Deputy Managing Director)

Ms Edith SHIH

Non-executive Directors: Mr CHOW Kun Chee, Roland

Mrs CHOW WOO Mo Fong, Susan

• Mr LEE Yeh Kwong, Charles

• Mr LEUNG Siu Hon

• Mr George Colin MAGNUS

Independent Non-executive Directors: Mr KWOK Tun-li, Stanley

Mr CHENG Hoi Chuen, Vincent

The Hon Sir Michael David KADOORIE Ms LEE Wai Mun, Rose

• Mr William Elkin MOCATTA (Alternate to The Hon Sir Michael David Kadoorie)

• Mr William SHURNIAK

• Mr WONG Chung Hin

Dr WONG Yick-ming, Rosanna